Peer Review History

Original SubmissionMay 6, 2021
Decision Letter - Frank T Kolligs, Editor

PONE-D-21-14958

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing

PLOS ONE

Dear Dr. Toes-Zoutendijk,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please respond to the comments made by the reviewers and revise your manuscipt accordingly.

Please ensure that your decision is justified on PLOS ONE’s publication criteria and not, for example, on novelty or perceived impact.

For Lab, Study and Registered Report Protocols: These article types are not expected to include results but may include pilot data. 

==============================

Please submit your revised manuscript by Oct 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Frank T Kolligs, MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the ethics statement in the manuscript methods and the online submission form, please state whether the authors were involved in data collection, or had access to any identifying patient information at any time. Please also provide additional details about what information patients were provided about the use of their data for scientific research, and how they were able to opt out.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript.

6.  Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Van der Meulen et al present a retrospective population based study assessing whether the average socioeconomic status of the region where someone lives is associated with colorectal cancer screening uptake and diagnostic yield. The authors find a lower rate of screening in those people living in neighbourhoods with the lowest socioeconomic status, however the detection rate per FIT test performed was highest in those people living in these lower socioeconomic regions.

The major limitation is that the socioeconomic status is defined by a person’s geographic region rather than patient level data. However, this is a common issue with these types of studies and the results are important. I am supportive of accepting a revised manuscript.

Major Issues:

1. Please include more details in the methods about how the multivariate models were constructed, assumptions used, and in the results include information about how other variables impacted screening use and yield.

Minor Issues:

2. The word “program” is spelled program in some places and programme in others.

3. The paragraph formatting in the introduction is odd with some paragraphs having 1-2 sentences. These paragraphs should be merged.

4. Under methods they state that ScreenIT collects gender. They likely mean sex and not gender data is captured.

5. It would likely translate better to describe quintile 5 as the lowest socioeconomic status rather than the most deprived. For quintile 1, I would describe this as the highest socioeconomic status. This is just an optional style consideration and not mandatory.

Reviewer #2: This is a clearly written paper focussing on an important aspect of colorectal cancer screening on an epidemiological level. The methods used are described in an understandable way, the presentation of the results in text and tables is clear and precise. Finally, the interpretation of the results in the discussion section is very comprehensible. Two aspects may be mentioned in this context. The limitation attributed to failing personal SES is critically addressed. Of utmost imporatnce is the statement that CRC screening has the potential to reduce socioeconomically driven health inequalities instead of augmenting them.

I do not have any major criticisms, just some minor comments and suggestions.

Introduction, page 5, 2nd sentence: „Sreening can prevent part of these deaths“: This is expressed in an very conservative way! I woulf favor: „Screening can prevent a considerable part of theses deaths“.

Methods, page 7, last line: „DR“: write: detection rate (DE).

Methods, page 8, data availability: „FSB“: explain abbreviation!

Results, page 9, Participation and positivity rate: „7,2%“ – in table 2: 7,1%

Table 4 was missing, only legend.

Reviewer #3: Important study, well designed and focussed on a difficult topic which has been underestimated so far. Socioeconomic differences in relation to colorectal screening programs should be much more adressed. The study gives insights how this problem can be explained and possibly may be managed.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Reviewer #1:

Major Issue:

1. Please include more details in the methods about how the multivariate models were constructed, assumptions used, and in the results include information about how other variables impacted screening use and yield.

Response: We thank the reviewer for this suggestion for clarification. We added a sentence to the methods. As sex and gender is not the focus of the paper, we only added the p-value of these factors to the results:

Page 8, second paragraph:

“Logistic regression analysis was performed to estimate odds ratio (OR) of the quintiles on FIT participation rate, positivity rate, colonoscopy uptake, PPV for AN and for CRC and detection rate per invitee for AN and for CRC. In this multivariable regression, outcomes were corrected for well-known confounders: age (continuous) and sex.“

Page 10:

“In all logistic regression analysis, age and sex were significant variables (p < 0.001).”

Minor Issues:

2. The word “program” is spelled program in some places and programme in others.

3. The paragraph formatting in the introduction is odd with some paragraphs having 1-2 sentences. These paragraphs should be merged.

4. Under methods they state that ScreenIT collects gender. They likely mean sex and not gender data is captured.

5. It would likely translate better to describe quintile 5 as the lowest socioeconomic status rather than the most deprived. For quintile 1, I would describe this as the highest socioeconomic status. This is just an optional style consideration and not mandatory.

Response: We thank the reviewer for pointing out these 4 issues, we have processed all 4 throughout the document.

Reviewer #2:

1. Introduction, page 5, 2nd sentence: „Sreening can prevent part of these deaths“: This is expressed in an very conservative way! I woulf favor: „Screening can prevent a considerable part of theses deaths“.

2. Methods, page 7, last line: „DR“: write: detection rate (DE).

3. Methods, page 8, data availability: „FSB“: explain abbreviation!

Response: We thank the reviewer for promoting these 3 clarifications, we have processed these in the document at the location as mentioned by the reviewer.

4. Results, page 9, Participation and positivity rate: „7,2%“ – in table 2: 7,1%

Response: We thank the reviewer for noticing this error. The correct result is in the table, 7,1%, we adjusted the text on page 9.

5. Table 4 was missing, only legend.

Response: We apologize for the omission of Table 4. We have now carefully checked to include this Table.

Attachments
Attachment
Submitted filename: Response to reviewers comments_20220111.docx
Decision Letter - Frank T Kolligs, Editor

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing

PONE-D-21-14958R1

Dear Dr. ToesZoutendijk,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Frank T Kolligs, MD

Academic Editor

PLOS ONE

Formally Accepted
Acceptance Letter - Frank T Kolligs, Editor

PONE-D-21-14958R1

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing

Dear Dr. Toes-Zoutendijk:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Frank T Kolligs

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .